Aslam Ejaz, MD
University of Illinois Chicago · University of Illinois at Chicago (UIC) · Ohio State University Comprehensive Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aslam Ejaz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:27 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07796997 · GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial PancreatectomyUniversity of Illinois Chicago · not yet recruiting · Pancreatic Cancer, Pancreatic Adenocarcinoma, Duodenal Cancer · principal investigator
- Ph2NCT07581405 · GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric CancerUniversity of Illinois Chicago · recruiting · Gastric Adenocarcinoma, Gastric Cancer · principal investigator
- Ph2NCT04992507 · Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS StudyOhio State University Comprehensive Cancer Center · terminated · Pancreatic Adenocarcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.